昂利康：子公司获“阿莫西林克拉维酸钾片”兽药产品批准文号

Core Viewpoint - The announcement indicates that the subsidiary of the company, Animal Health Technology, has received approval from the Ministry of Agriculture and Rural Affairs for the veterinary drug "Amoxicillin Clavulanate Potassium Tablets" with a validity period from October 24, 2025, to October 23, 2030 [1] Group 1 - The approved product has two specifications: 50mg and 250mg, and is intended for the treatment of bacterial infections in dogs and cats [1] - The approval signifies that the product meets the conditions for production and market sales, which will enhance the company's product range and support its strategic layout in pet medication [1] - However, the market launch may face uncertainties due to factors such as policies and market conditions [1]